The guiding principles of the members of GBMA are:
To make high quality medicines affordable for all Australians today and for the future
To support the long term sustainability of the PBS by ensuring the timely and cost effective provision of generic and biosimilar medicines to consumers.
To support the quality use of medicines (QUM) in partnership with other stakeholders.
To support the development of policies that facilitate timely access to generic and biosimilar medicines for all Australians.
To support the development of policies that promote the continued viability of a local manufacturing base for generic and biosimilar medicines (for domestic and export markets).
To encourage a high level of awareness and general knowledge of the safety, efficacy and appropriate interchangeability of generic and biosimilar medicines amongst healthcare professionals, Government and consumers.
To support balanced intellectual property rights in the pharmaceutical sector that enable timely, cost-effective access to generic and biosimilar medicines.
To enhance the accountability of Members by establishing a complaints handling mechanism that is both readily accessible and transparent.
To ensure high standards of conduct by adhering to a strict Code of Practice
